Clinical Trials on DMG in Canada
Total 11 results
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval UniversityCompletedHMG COA Reductase Inhibitor Adverse ReactionCanada
-
McGill University Health Centre/Research Institute...WithdrawnHMG COA Reductase Inhibitor Adverse ReactionCanada
-
BayerRegeneron PharmaceuticalsCompletedDiabetic Macular Edema (DME) | Age-related Macular Degeneration (AMD) | Central Retinal Vein Occlusion (CRVO)Canada
-
Université du Québec à ChicoutimiRecruitingMyotonic Dystrophy Type 1 (DM1)Canada
-
Vertex Pharmaceuticals IncorporatedRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, Canada
-
Unity Biotechnology, Inc.CompletedDiabetic Macular Edema (DME)United States, Canada
-
Hoffmann-La RocheTerminatedMuscular Dystrophy (DMD)United States, Canada
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
Unity Health TorontoCompletedChronic Obstructive Pulmonary Disease (COPD) | Congestive Heart Failure (CHF) | Diabetes Mellitus (DM)Canada
-
Dyne TherapeuticsRecruitingDuchenne Muscular Dystrophy (DMD)United States, Belgium, Canada, United Kingdom, Australia, Spain, Italy
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland